0001236031-12-000010.txt : 20120612 0001236031-12-000010.hdr.sgml : 20120612 20120612175614 ACCESSION NUMBER: 0001236031-12-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120612 FILED AS OF DATE: 20120612 DATE AS OF CHANGE: 20120612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZIMMERMAN DANIEL H CENTRAL INDEX KEY: 0001236028 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 12903812 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 4 1 primary_doc.xml PRIMARY DOCUMENT X0305 4 2012-06-12 0 0000725363 CEL SCI CORP cvm 0001236028 ZIMMERMAN DANIEL H 0 1 0 0 Senior Vice President Options 0.39 2012-06-12 4 A 0 225000 0 A 2022-05-17 Common Stock 225000 1659000 D The stock options vest in three (3) equal annual installments commencing one year after the grant date. Daniel Zimmerman 2012-06-12